Compliance & Validation — Not documented by Atlas
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
Endpoint Clinical
IRT/RTSM specialist (PULSE platform) for randomization and trial supply management in clinical trials.
Endpoint Clinical, founded in 2009 and headquartered in Raleigh, North Carolina, is an interactive response technology (IRT/RTSM) specialist whose PULSE platform manages randomization, drug assignment, and trial supply for clinical studies. Arsenal Capital Partners acquired the business from Fortrea in June 2024, returning it to standalone private-equity ownership. Atlas found no vendor-held security certifications documented on its site.
- Headquarters
- Raleigh, United States
- Founded
- 2009
- Deployment options
- cloud
- Website
- https://www.endpointclinical.com
- https://www.linkedin.com/company/endpoint_464541
Categories
AI Use Cases
- Clinical Data Management
Vendor Scorecard
50% — Partial coverage. Coverage score — how completely Atlas documents Endpoint Clinical across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Deployment & Hosting — Documented
cloud
Pricing Transparency — Not documented by Atlas
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Implementation & Onboarding — Not documented by Atlas
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Organization & Role Fit — Documented
Mid-Size Biotech, Large Pharma, Top 20 Pharma, CRO / CDMO, Clinical Operations, Data Management
Solution Scope — Documented
Clinical Data Management
Company Viability — Partially documented
Private equity, Founded 2009
Always ask the vendor
Not captured in Atlas data — confirm directly. Excluded from the score above.
Data Rights & IP
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Model Credibility & Explainability
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?
Questions to Ask This Vendor
- What is the typical PULSE study build timeline for our protocol complexity?
- How are mid-study changes to randomization or supply strategy handled?
- How has the transition from Fortrea to Arsenal ownership affected support and roadmap?
- What validation documentation is provided per study for regulated use?